Viral Testing Systems
This article was originally published in The Gray Sheet
Executive SummaryFirm's Fluorognost HIV-1 immunofluorescent assay (IFA) test is successful in detecting a "set of African AIDS virus variants" termed "Subtype O," VTS announces. At the recent International Conference on AIDS in Yokohama, Japan, researchers from the Centers for Disease Control and Prevention investigated the performance of nine FDA-licensed diagnostic tests to detect the new "Subtype O" strain. Only three of the tests, including VTS' Fluorognost, were able to identify specimens 100% of the time as positive, the firm says. The Fluorognost IFA was the first HIV-1 diagnostic to be marketed as both a screening and confirmation test ("The Gray Sheet" March 2, 1992, p. 9)
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.